Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

Trine A. Knudsen; Dennis Lund Hansen; Lukas Frans Ocias; Ole Weiss Bjerrum; Mette Brabrand; Sarah  Friis Christensen; Christina Schjellerup Eickhardt-Dalbøge; Christina Ellervik; Daniel El Fassi; Mikael Frederiksen; Lasse Kjær; Thomas Kielsgaard Kristensen; Torben Arvid Kruse; Morten Kranker Larsen; Hans Torben Mourits-Andersen; Ulrik Malthe  Overgaard; Marianne Tang Severinsen; Vibe Skov; Anders Lindholm Sørensen; Jesper Stentoft; Jørn Starklint; Karin de Stricker; Mads Thomassen; Thomas Stauffer Larsen; Hans Carl  Hasselbalch

doi:10.1182/blood-2022-156445

Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

Trine A. Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Weiss Bjerrum, Mette Brabrand, Sarah Friis Christensen, Christina Schjellerup Eickhardt-Dalbøge, Christina Ellervik, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben Arvid Kruse, Morten Kranker Larsen, Hans Torben Mourits-Andersen, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Anders Lindholm Sørensen, Jesper StentoftJørn Starklint, Karin de Stricker, Mads Thomassen, Thomas Stauffer Larsen, Hans Carl Hasselbalch

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Blood
Vol/bind	140
Udgave nummer	Suppl. 1
Sider (fra-til)	1794–1796
ISSN	0006-4971
DOI	https://doi.org/10.1182/blood-2022-156445
Status	Udgivet - 15. nov. 2022
Begivenhed	64th ASH Annual Meeting & Exposition 2022 - New Orleans, USA Varighed: 10. dec. 2022 → 13. dec. 2022

Konference

Konference	64th ASH Annual Meeting & Exposition 2022
Land/Område	USA
By	New Orleans
Periode	10/12/2022 → 13/12/2022

Dokumenter og links

10.1182/blood-2022-156445

Citationsformater

Knudsen, T. A., Hansen, D. L., Ocias, L. F., Bjerrum, O. W., Brabrand, M., Friis Christensen, S., Eickhardt-Dalbøge, C. S., Ellervik, C., El Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T. A., Kranker Larsen, M., Mourits-Andersen, H. T., Overgaard, U. M., Severinsen, M. T., Skov, V., Sørensen, A. L., ... Hasselbalch, H. C. (2022). Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial. Blood, 140(Suppl. 1), 1794–1796. https://doi.org/10.1182/blood-2022-156445

@article{681ffc3adb124bc59a6e1e0dde127152,

title = "Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial",

author = "Knudsen, {Trine A.} and Hansen, {Dennis Lund} and Ocias, {Lukas Frans} and Bjerrum, {Ole Weiss} and Mette Brabrand and {Friis Christensen}, Sarah and Eickhardt-Dalb{\o}ge, {Christina Schjellerup} and Christina Ellervik and {El Fassi}, Daniel and Mikael Frederiksen and Lasse Kj{\ae}r and {Kielsgaard Kristensen}, Thomas and Kruse, {Torben Arvid} and {Kranker Larsen}, Morten and Mourits-Andersen, {Hans Torben} and Overgaard, {Ulrik Malthe} and Severinsen, {Marianne Tang} and Vibe Skov and S{\o}rensen, {Anders Lindholm} and Jesper Stentoft and J{\o}rn Starklint and {de Stricker}, Karin and Mads Thomassen and Larsen, {Thomas Stauffer} and Hasselbalch, {Hans Carl}",

year = "2022",

month = nov,

day = "15",

doi = "10.1182/blood-2022-156445",

language = "English",

volume = "140",

pages = "1794–1796",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "Suppl. 1",

note = "64th ASH Annual Meeting & Exposition 2022<br/> ; Conference date: 10-12-2022 Through 13-12-2022",

}

Knudsen, TA, Hansen, DL, Ocias, LF, Bjerrum, OW, Brabrand, M, Friis Christensen, S, Eickhardt-Dalbøge, CS, Ellervik, C, El Fassi, D, Frederiksen, M, Kjær, L, Kielsgaard Kristensen, T, Kruse, TA, Kranker Larsen, M, Mourits-Andersen, HT, Overgaard, UM, Severinsen, MT, Skov, V, Sørensen, AL, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M , Larsen, TS & Hasselbalch, HC 2022, 'Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial', Blood, bind 140, nr. Suppl. 1, s. 1794–1796. https://doi.org/10.1182/blood-2022-156445

Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial. / Knudsen, Trine A.; Hansen, Dennis Lund; Ocias, Lukas Frans et al.

I: Blood, Bind 140, Nr. Suppl. 1, 15.11.2022, s. 1794–1796.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

AU - Knudsen, Trine A.

AU - Hansen, Dennis Lund

AU - Ocias, Lukas Frans

AU - Bjerrum, Ole Weiss

AU - Brabrand, Mette

AU - Friis Christensen, Sarah

AU - Eickhardt-Dalbøge, Christina Schjellerup

AU - Ellervik, Christina

AU - El Fassi, Daniel

AU - Frederiksen, Mikael

AU - Kjær, Lasse

AU - Kielsgaard Kristensen, Thomas

AU - Kruse, Torben Arvid

AU - Kranker Larsen, Morten

AU - Mourits-Andersen, Hans Torben

AU - Overgaard, Ulrik Malthe

AU - Severinsen, Marianne Tang

AU - Skov, Vibe

AU - Sørensen, Anders Lindholm

AU - Stentoft, Jesper

AU - Starklint, Jørn

AU - de Stricker, Karin

AU - Thomassen, Mads

AU - Larsen, Thomas Stauffer

AU - Hasselbalch, Hans Carl

PY - 2022/11/15

Y1 - 2022/11/15

U2 - 10.1182/blood-2022-156445

DO - 10.1182/blood-2022-156445

M3 - Conference abstract in journal

SN - 0006-4971

VL - 140

SP - 1794

EP - 1796

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 64th ASH Annual Meeting & Exposition 2022<br/>

Y2 - 10 December 2022 through 13 December 2022

ER -